Evidence map›Paper›PMID 29335641›Full record

ArticleThe ISME journal2018

Benefit from decline: the primary transcriptome of Alteromonas macleodii str. Te101 during Trichodesmium demise.

Shengwei Hou, Mario López-Pérez, Ulrike Pfreundt, Natalia Belkin, Kurt Stüber, Bruno Huettel, Richard Reinhardt, Ilana Berman-Frank, Francisco Rodriguez-Valera, Wolfgang R Hess

Open access · hybridAbstract read
In one paragraph

Article in The ISME journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. mBio · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Marine bacteriamBio · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bacteria Associated WithFrontiers in microbiology · 2022
    Article
  14. Article
  15. Article
  16. Diatom modulation of select bacteria through use of two unique secondary metabolites.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Shengwei HouFaculty of Biology, University of Freiburg, Schänzlestr. 1, D-79104, Freiburg, Germany.ORCID http://orcid.org/0000-0002-4474-7443
Mario López-PérezEvolutionary Genomics Group, División de Microbiología, Universidad Miguel Hernández, Apartado 18, San Juan, 03550, Alicante, Spain.
Ulrike PfreundtFaculty of Biology, University of Freiburg, Schänzlestr. 1, D-79104, Freiburg, Germany.
Natalia BelkinMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, 52900, Israel.
Kurt StüberMax Planck-Genome-Centre Cologne, Carl-von-Linné-Weg 10, D-50829, Köln, Germany.
Bruno HuettelMax Planck-Genome-Centre Cologne, Carl-von-Linné-Weg 10, D-50829, Köln, Germany.
Richard ReinhardtMax Planck-Genome-Centre Cologne, Carl-von-Linné-Weg 10, D-50829, Köln, Germany.
Ilana Berman-FrankMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, 52900, Israel.
Francisco Rodriguez-ValeraEvolutionary Genomics Group, División de Microbiología, Universidad Miguel Hernández, Apartado 18, San Juan, 03550, Alicante, Spain.ORCID http://orcid.org/0000-0002-9809-2059
Wolfgang R HessFaculty of Biology, University of Freiburg, Schänzlestr. 1, D-79104, Freiburg, Germany. wolfgang.hess@biologie.uni-freiburg.de.
Max Planck Institute for Plant Breeding Research · DEUniversity of Freiburg · DEBar-Ilan University · ILUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interactions between co-existing microorganisms deeply affect the physiology of the involved organisms and, ultimately, the function of the ecosystem as a whole. Copiotrophic Alteromonas are marine gammaproteobacteria that thrive during the late stages of phytoplankton blooms in the marine environment and in laboratory co-cultures with cyanobacteria such as Trichodesmium. The response of this heterotroph to the sometimes rapid and transient changes in nutrient supply when the phototroph crashes is not well understood. Here, we isolated and sequenced the strain Alteromonas macleodii str. Te101 from a laboratory culture of Trichodesmium erythraeum IMS101, yielding a chromosome of 4.63 Mb and a single plasmid of 237 kb. Increasing salinities to ≥43 ppt inhibited the growth of Trichodesmium but stimulated growth of the associated Alteromonas. We characterized the transcriptomic responses of both microorganisms and identified the complement of active transcriptional start sites in Alteromonas at single-nucleotide resolution. In replicate cultures, a similar set of genes became activated in Alteromonas when growth rates of Trichodesmium declined and mortality was high. The parallel activation of fliA, rpoS and of flagellar assembly and growth-related genes indicated that Alteromonas might have increased cell motility, growth, and multiple biosynthetic activities. Genes with the highest expression in the data set were three small RNAs (Aln1a-c) that were identified as analogs of the small RNAs CsrB-C in E. coli or RsmX-Z in pathogenic bacteria. Together with the carbon storage protein A (CsrA) homolog Te101_05290, these RNAs likely control the expression of numerous genes in responding to changes in the environment.

Indexed as

TranscriptomeAlteromonasBacterial ProteinsMicrobial InteractionsRNA, Small UntranslatedSalinityTranscription Initiation SiteTrichodesmiumBacterial ProteinsRNA, Small Untranslated

Identifiers

PMID29335641
PMCPMC5864184
OpenAlexW2783911354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.